Last updated 2026-07-20
- Raised $1.6M Seed round led by Pontifax, May 2013
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
OCON Therapeutics develops innovative women's health products, with its primary product being the IUB (Intra Uterine Ball), a 3D spherical IUD designed to address issues of malposition and uterine wall perforations associated with traditional T-shaped IUDs. The company utilizes Nitinol, a shape-memory alloy, in its devices.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Business Software1
Q&A
- What is Ilan Baram's primary investment focus by sector?
- Ilan Baram has concentrated investments in the Business Software sector, with one portfolio company in this area.
- Has Ilan Baram had any notable exits?
- Yes, Ilan Baram had an exit in April 2021 when portfolio company Approve, an Enterprise Procurement SaaS, was acquired by Tipalti for $40M.
- What is Ilan Baram's most notable portfolio company?
- Ilan Baram's most notable portfolio company is Approve, an Enterprise Procurement SaaS company that was acquired by Tipalti in April 2021.
- When did Ilan Baram make his most recent investment?
- Ilan Baram's most recent recorded investment was in May 2019.
- What stage of companies does Ilan Baram typically invest in?
- Ilan Baram has invested in Pre-Seed stage companies.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2011 |
|---|
Radar intelligence
Patents
| EPO | 1 |
|---|